RELEGARD (BLANSETT PHARMACAL CO)
Welcome to the PulseAid listing for the RELEGARD drug offered from BLANSETT PHARMACAL CO. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | BLANSETT PHARMACAL CO |
NON-PROPRIETARY NAME: | GLACIAL ACETIC ACID, OXYQUINOLINE |
SUBSTANCE NAME: | ACETIC ACID; OXYQUINOLINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | TOPICAL |
DOSAGE FORM: | GEL |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2017-03-20 |
END MARKETING DATE: | 0000-00-00 |
RELEGARD HUMAN PRESCRIPTION DRUG Details:
Item Description | RELEGARD from BLANSETT PHARMACAL CO |
LABELER NAME: | BLANSETT PHARMACAL CO |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | .9; .025(mg/mL; mg/mL) |
START MARKETING DATE: | 2017-03-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51674-0130_85f9ed27-9fce-4cd5-9cb2-7dc9d6c06cb1 |
PRODUCT NDC: | 51674-0130 |
APPLICATION NUMBER: | |
Other ACETIC ACID; OXYQUINOLINE Pharmaceutical Manufacturers / Labelers: